European Patent Office

T 1014/01 (Recombinant immunoconjugates/BRISTOL-MYERS Squibb Co.) of 05.11.2003

European Case Law Identifier
ECLI:EP:BA:2003:T101401.20031105
Date of decision
5 November 2003
Case number
T 1014/01
Petition for review of
-
Application number
91100695.5
IPC class
A61K 47/48
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Recombinant immunoconjugates for therapy comprising interleukin 2
Applicant name
Bristol-Myers Squibb Company
Opponent name
Pharmacia & Upjohn S.p.A.
Edmund R Pitcher
Board
3.3.04
Headnote
-
Keywords
Main request - novelty (no)
Auxiliary request 1 - added subject-matter (yes)
Auxiliary request 2 - inventive step (no)
Auxiliary request 3 - inventive step (yes)
Catchword
-
Citing cases
-

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The matter is remitted to the first instance with the order to maintain the patent on the basis of:

Claims: Claims of New Auxiliary Request 3 submitted at oral proceedings on 5 November 2003

Description: Pages 2, 3, 4, 5, 6 and 8 as submitted at oral proceedings on 5 November 2003, Page 7 as granted

Figures: As granted

3. The requests by appellants II and III for apportionment of costs are refused.